NCAPD2 and prostate cancer: Previous research has demonstrated that poor prognosis is correlated to abnormal condensin complex I expression of the NCAPH, NCAPG, and NCAPD2 subunits in NSCLC, liver cancer, colorectal cancer, breast cancer, and prostate cancer [26–31].